Use of atropine eye drops for clozapine induced hypersalivation

被引:21
|
作者
Comley, C [1 ]
Galletly, C [1 ]
Ash, D [1 ]
机构
[1] NW Adelaide Mental Hlth Serv, Dept Psychiat, Adelaide, SA, Australia
来源
关键词
D O I
10.1046/j.1440-1614.2000.0840f.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:1033 / 1034
页数:2
相关论文
共 50 条
  • [21] Review: Insufficient evidence to guide use of drugs for clozapine induced hypersalivation COMMENTARY
    Sockalingam, Sanjeev
    Remington, Gary
    EVIDENCE-BASED MENTAL HEALTH, 2009, 12 (01) : 12 - 12
  • [22] CLOZAPINE-INDUCED HYPERSALIVATION TREATED WITH SULPIRIDE - IS IT A SOLUTION?
    Prljaca, Emir
    Becirovic, Elvir
    Hasanovic, Mevludin
    Pajevic, Izet
    Brigic, Anel
    PSYCHIATRIA DANUBINA, 2021, 33 : S165 - S166
  • [23] Clozapine-Induced Hypersalivation in a Geriatric Patient with Schizophrenia
    McAvoy, K. E.
    Bukowy, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S102 - S102
  • [24] Clozapine-induced hypersalivation: A review of treatment strategies
    Sockalingam, Sanjeev
    Shammi, Chekkera
    Remington, Gary
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (06): : 377 - 384
  • [25] Metoclopramide may be effective for clozapine-induced hypersalivation
    Hallahan, Brian
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (04) : 124 - 124
  • [26] Will the long-term use of atropine eye drops in children increase the risk of dry eye?
    Zhao, Feng
    Ma, Jing-xue
    MEDICAL HYPOTHESES, 2019, 132
  • [27] Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report
    Calderon, J
    Rubin, E
    Sobota, WL
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (01) : 49 - 52
  • [28] Reduction of clozapine-induced hypersalivation by pirenzepine is safe
    Schneider, B
    Weigmann, H
    Hiemke, C
    Weber, B
    Fritze, J
    PHARMACOPSYCHIATRY, 2004, 37 (02) : 43 - 45
  • [29] Amitriptyline for clozapine-induced hypersalivation: A case series
    Cereda, Guido
    Boscutti, Andrea
    Lazzaretti, Matteo
    Enrico, Paolo
    Brambilla, Paolo
    SCHIZOPHRENIA RESEARCH, 2022, 243 : 110 - 111